This study aimed to screen the bioactive components in Streptococcus equinus WC (SE-WC) and Limosilactobacillus reuteri GM (LR-GM) and estimate the therapeutic role in Ehrlich solid tumors (EST) mice model. Forty-four male albino EST mice were assigned into 7 groups and treated daily for 2 weeks, including the EST group, the EST mice that received SE-WC at a low or a high dose (0.5 ml *10 or 0.
View Article and Find Full Text PDF